Company: Radius Health
Based: Cambridge, MA
Investors: Oxford Bioscience Partners, HealthCare Ventures, Bellevue Asset Management, Undisclosed Firm, MPM Capital
Scoop: Radius Health, which develops osteoporosis and women's health meds, raised $43.3M to advance the company's clinical and preclinical development programs. It's lead candidate is BA058, a bone anabolic therapy for the treatment of osteoporosis, which is in Phase II trials. Additionally, the company is working to move RAD1901 for hot flashes into Phase III studies.